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Structural  heterogeneity of variable region domains of immunoglobulins is 
enormous because of the unique genetic mechanisms for generating antibody 
diversity. Variable regions of heavy chains (VH)  l are  encoded by three gene 
segments, V., D, and Jn, that exist in multiple copies in the genome and that 
recombine randomly upon immunologic commitment (1-3). Similarly,  variable 
regions of light chains are encoded by two gene segments, VK and JK or Vx and 
Jx (4-6).  The combinatorial joining of gene segments expands the number of 
protein products geometrically. Second, the joining process itself is imprecise so 
that diversity at the junction of gene segments occurs (7, 8). Both combinatorial 
joining and junctional diversity mechanisms lead to extreme variability  in the 
third hypervariable regions of the heavy and light chains, which are particularly 
important regions of the binding site. Third, special time-dependent mutational 
mechanisms lead to single base  changes scattered throughout the recombined 
variable region genes leading to further protein diversification (9-12). 
More than  20  years  ago,  Kunkel (13)  showed that the structural  diversity 
expressed  by variable  region domains could  be detected by antisera.  These 
variable  region antigenic determinants, called idiotopes, provide simple and 
highly specific ways of identifying  and comparing variable regions and have been 
widely used  in  immunological research.  Potentially, any part  of the variable 
domains may express idiotopes and, indeed, a wide variety of these determinants 
have been described, including those located within or outside the binding site, 
on VL or VH domains, and on the complex of VL-VH (14--17). The totality of 
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idiotopes  on  an  individual  immunoglobulin, called  an  idiotype,  constitutes  a 
unique set of markers highly characteristic of each protein. Indeed, Kunkel (18) 
used idiotypic analysis to estimate that the variable region repertoire of humans 
exceeded 107 . 
Molecules that share idiotypes could be expected to be structurally and even 
functionally similar and there are many examples where this is the case (9,  17). 
Antibodies with the same antigen specificity often share idiotypic determinants 
and this has been shown to reflect common genetic origins and similar structure. 
In addition, however,  molecules that do not share  genetic origins, but  which 
have affinity for the same ligand, such as antibodies and T  cell receptors specific 
for the same antige  n (19), and antibodies and cell receptors specific for the same 
hormones (20),  have also been shown to share idiotopes. Thus, some idiotopes 
are functional markers. 
In  addition  to  providing  useful  markers  for  investigating  variable  region 
structure  and  function,  it  has  become  clear  that  idiotypes  may  provide  an 
important means of immune regulation. Jerne (2 I) first called attention to the 
possibility that idiotopes on lymphocyte receptors may be recognized by other 
lymphocyte receptors with antiidiotope specificity, forming the idiotype network; 
antibodies, suppressor T  cells, and helper T cells have all been shown to recognize 
idiotopes and  to  augment or  suppress  idiotype production  (22-24).  Further, 
antibodies to idiotypic determinants when passively administered result in the 
elimination of lymphocytes bearing the idiotype (25). If these cells are malignant, 
antiidiotypic antisera can be an effective therapy (26). Potentially, if the idiotype 
is shared by a  family of autoimmunity-causing clones, antiidiotypic therapy may 
be curative. 
Thus, idiotypic determinants are extremely important from several viewpoints. 
It is disappointing to realize that the molecular definition of an idiotope has been 
accomplished in only a  few instances (I7).  Inability to make molecular assign- 
ments of idiotype is due, in part, to the complexity of the process of assignment. 
Required are both monospecific antiidiotypic antibody and families of idiotype- 
positive and  -negative  immunoglobulins that  are  both completely structurally 
characterized and sufficiently similar/dissimilar so that the correlation of idiotype 
with structure  can be  made by inspection.  In the few cases in which idiotype 
expression can  be  correlated  with certain  amino acid  residues,  it  is not  clear 
whether the idiotope is present on these critical residues or,  alternatively,  on 
others influenced by the critical residues. 
To date, idiotypes have been defined following immunization of animals with 
intact immunoglobulin. Recently, however, synthetic peptides have been used to 
generate antibodies that bind both peptide and proteins bearing that sequence 
(27-29).  We  have  applied  this  strategy  to  immunoglobulins in  an  effort  to 
generate site-specific antiidiotypic reagents (30, 3 I). Here we show that a peptide 
corresponding to JH1 of murine Vn regions stimulates a variety of antibodies to 
immunoglobulin determinants at least some of which are  found preferentially 
on families of antibodies with the same specificity. This indicates that a  short, 
relatively  constant  part  of  variable  domains  actually  forms  part  or  all  of a 
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Materials and Methods 
Animals.  New Zealand white rabbits were obtained from Isaacs Lab Stock, Litchfield, 
IL. Sprague Dawley outbred rats were obtained from Harlan Sprague Dawley, Indianap- 
olis, IN. 
Peptide Synthesis.  Peptides  were  synthesized  manually  from  free amino  acids  using 
standard Merrifield techniques (32).  Finished peptides were cleaved from the resin with 
hydrofluoric acid  (HF),  characterized by thin  layer chromatography, and  purified by 
partition chromatography on G-25 Sephadex. Confirmation of the JHI peptide structure 
was obtained by amino acid sequence analysis.  Bombesin, a  tetradecapeptide hormone, 
was obtained commercially (Sigma Chemical Co., St. Louis, MO). 
hnmunogen.  JH, and bombesin peptides were coupled via glutaraldehyde (Sigma)  to 
Keyhole limpet hemocyanin (KLH; Calbiochem-Behring Corp.,  San  Diego, CA) as de- 
scribed  previously (33).  Influenza  hemagglutinin  peptide  (HA)  was  coupled  to  KLH 
through  cysteine  using  n-maleimidobenzoyl-N-hydroxy-succinimide ester  as  described 
elsewhere (34). 
hnmunization.  Rabbits were immunized subcutaneously with 0.5  mg of JH~-KLH in 
complete Freund's adjuvant (CFA; Difco Laboratories, Detroit, MI). Rats were immunized 
with  0.1  mg of JHI-KLH or Bombesin-KLH i.p.  Animals were boosted with  0.1  mg of 
JH~-KLH in incomplete Freund's adjuvant (IFA; Difco). Control rabbit sera were prepared 
using a similar protocol and are described elsewhere (35). 
Antibody Assays.  Indirect and direct radioimmune assay  (RIA)  have been described 
previously (36).  Briefly, 1 •g/ml  of antigen in phosphate-buffered saline (PBS) was used 
to coat 96-well microtiter plates (Cooke Laboratory and Products, Alexandria, VA). After 
blocking unoccupied protein sites with 1% bovine serum albumin (BSA)/PBS, the antigen- 
coated plates were exposed to fourfold serial dilutions ofanti-JHi-KLH antisera for several 
hours. The presence of rabbit antibody bound was detected with 2 ×  105 cpm of ~2~I-goat 
anti-rabbit IgG (37) (Gateway Labs, St. Louis, MO). Plates were washed and counts bound 
were determined in a gamma counter. 
Indirect RIA was used to measure the specificity of binding. Fourfold serial dilutions 
5  125  of purified inhibitors were mixed with 4 ×  10  cpm of  I-myeloma proteins and exposed 
to microtiter plates coated with a  1:1,000 dilution of rabbit anti-JH~-KLH. After 4 h of 
incubation, the wells were washed and radioactivity was measured. 
Protein Purification.  Most proteins used in this study were affinity purified on Sepharose 
4B  columns  conjugated  with  the  appropriate  ligand  as  described elsewhere (38,  39). 
Hybridoma-derived proteins  l-B-10, 6A6, and group A carbohydrate (GAC)  123 were 
used  as  concentrated  serum-free tissue  culture  supernatants. J606  was  purified from 
ammonium sulfate precipitates of ascites followed by three consecutive euglobulin precip- 
itations. 
SDS-PAGE and Western Blot Transfer.  M 104 and low molecular weight standards (Bio- 
Rad Laboratories, Richmond, CA) were denatured and reduced by brief boiling in  1% 
sodium dodecyl sulfate (SDS) and  1%  2-mercaptoethanol (2ME).  Standards and immu- 
noglobulin heavy and light chains were separated by discontinuous SDS-polyacrylamide 
gel electrophoresis (PAGE) on a  12.5% gel.  Separated proteins were electrically trans- 
ferred to nitrocellulose (Schleicher &  Schuell,  Inc.,  Keene,  NH)  in a  transfer box as 
described elsewhere (40). Efficiency of separation and transfer was determined by amido- 
blue black stain of the proteins on the nitrocellulose paper. 
After transfer, the nitrocellulose was exposed to 1% BSA, 0.05% Tween 20 (Sigma) in 
PBS.  Individual  strips  were  incubated in  BSA/Tween/PBS with a  1:2,000  dilution of 
antisera.  After a  1-h  incubation  with  the  first  antibody,  the  strips  were  washed  and 
incubated for 1 h  with 2  ×  10  n cpm of ~SI-labeled protein A  (Sigma).  The strips were 
washed overnight with BSA/Tween/PBS and exposed to x-ray for 24 h at -70°C. 
Isoelectric Focusing.  Serum antibodies were characterized by IEF in a 0.9% agarose gel 
(41) (FMC Corp., Rockland, ME) containing 2.5% LKB ampholytes 5-8 and 2.5% LKB 
ampholyte 8-9.5 (LKB, Gaithersburg, MD).  1-4/A of sera were applied to prepunched 
wells between a cathodal wick saturated with 100 mM NaOH or imidazole and an anodal 
wick saturated with  100 mM phosphoric acid or glycylglycine. Proteins were separated SEIDEN  ET  AL.  1341 
with  12 W constant power until the voltage was over 1,000 V. Immunoglobulins were 
precipitated with  18% sodium sulfate for 20  rain,  fixed with 0.01%  glutaraldehyde in 
sodium sulfate for 20 min, and washed extensively. Fixed gels were incubated for 1-2 h 
with 10 x  108 cpm of l*SI-labeled myeloma protein or normal mouse IgG (42). Gels were 
then washed for 36 h on a rotary shaker, dried, and exposed to film at -70°C for 1-7 d. 
Results 
Anti-peptide  Sera  Bind  Both  Peptide  and  Immunoglobulin.  Table  I  shows  the 
sequences and relative positions of the mouse JH segments in the VH domain. 
The N-terminal region of JH is part of HV3 and intrudes into the binding site. 
The remainder of  Jn lies in the groove separating the VL and VH domains (43). 
The C-terminus provides the link with the CH~ domain. 
A  peptide  corresponding to JH1  was  synthesized (Table  I) and  coupled  to 
KLH; rats and rabbits were immunized with the conjugate and their sera tested 
for antibody. Results achieved with a representative serum are shown in Fig.  1. 
It is clear that JH~-KLH induces antibodies that bind both peptide and immu- 
noglobulins (Fig.  1). Anti-JHt binds JHl peptide best, but also cross-reacts with 
the JH2 peptide. Only minimal binding is seen with the 15-amino acid peptide 
corresponding to the first hypervariable region of MOPC 104 heavy chain (HV 1- 
M 104; Fig.  1 a). Further, the same antiserum binds substantial amounts of four 
monoclonal antibodies specific for three separate carbohydrate antigens (Fig. 1 b) 
known to  have different variable  region structures (9,  17,  44).  Western blot 
analysis shows that the anti-immunoglobulin reactivity is heavy chain specific and 
is capable of detecting denatured heavy chains (Fig.  2, lane 1). The doublet at 
70,000 is the glycosylated and deglycosylated M 104 heavy chain as determined 
by trifluoromethanesulfonic (TFMS) acid deglycosylation experiments (data not 
shown).  The  fainter  band  at  ~31,000  is  probably  a  heavy chain  breakdown 
product and has been reported previously (31). The serum shows no activity for 
light chain (lane 1) or numerous other proteins described in the figure legend 
(lane  2).  A  rabbit  immunized with  KLH-HA  (sera  3630)  in  CFA  showed no 
activity for immunoglobulin heavy or light chain or numerous other proteins 
(lanes 3 and 4). 
Identification  of Antiidiotope  Antibodies.  Direct binding RIA demonstrate that 
anti-JH] sera bind several immunoglobulins, but cannot determine whether one 
TABLE  I 









*(  97-100F  )  101  102  103  lOq  105  106  107  108  109  110  111  112  113  C 
TYR-TRP-TYR-PHE-ASP-VAL-TRP-GLY-ALA-GL¥-THR-THR-VAL-THR-VAL-SER-SER 
ASP  .............  TYR  .........  GLN  .............  LEU  ................ 
ALA-TRP  .....  ALA-TYR  .........  GLN  .........  LEU  .................  ALA 
ASP-TYR-TYR-ALA-MET  .....  TYR  .........  GLM  .........  SER  .................... 
................................................................  LYS 
TYR  .............  TYR  .........  GLM  .............  LEU  .................  LYS 
JH]q are  the  four germline Jn sequences  used in BALB/c mice (53).  Peptides JIsr~ and Jzs~ were manually synthesized  and 
characterized by TLC and amino acid composition, and in the case ofJjs~ peptide, by amino acid sequence analysis. 
* Kabat numbers denoting position of  J segments in the VM region. N-terminal position assignments will vary depending on length of 
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FIGURE l.  Binding  of anti-JHi to peptide and various hybridoma and myeloma  proteins. A) 
Binding profiles of JH~ immunized rabbit sera to various peptides. JH1 (0); JH2 (A); HV1- 
MI04 (11) or BSA alone (×). (B) Binding of anti-JH~ to T15 (A); M104 (O), GAC34 (A), or 
J558 (0). The sequence of HV1 M104 is Cys-Ser-Gly-Tyr-Thr-Phe-Thr-Asp-Tyr-Tyr-Met- 
Lys-Trp-VaI-Lys. 
or  more  specificities are  expressed  within  a  given  serum.  Several  approaches 
were used to examine this question. First, anti-peptide sera from several animals 
were examined, following isoelectric focusing (IEF) in agarose gels, for binding 
to various labeled immunoglobulin ligands. This technique permits rapid screen- 
ing of sera for anti-immunoglobulin  reactivity, evaluates heterogeneity of anti- 
body activity, permits comparison between different anti-peptide sera, and, most 
importantly,  allows  comparison  of the  heterogeneity  and  isoelectric  point  of 
antibodies in a  single serum that  binds different ligands.  In Fig.  3, a  variety of 
anti-JH1 sera (T and numbered samples) and control sera from animals immune 
to a  variety of irrelevant  KLH-coupled peptides (a-d and w-z) were focused on 
four separate  gels,  which  were subsequently exposed to  ~2~I-IgG from  normal 
mouse serum,  125I-J558,  an o~ anti-dextran  antibody,  125I-Ti5,  an o~K anti-PC 
antibody, and  ~25I-GAC34,  a ~,sK anti-GAC antibody. Autoradiographs of these 
gels show that  all anti-JH~  sera bind normal  mouse IgG (panel A).  None of 12 
rabbit (data for 4  shown) and  4  rat antisera  raised to irrelevant  peptides have 
this specificity. The anti-IgG activity is heterogeneous with a slight suggestion of 
shared bands between sera. Very different patterns are seen when homogeneous 
immunoglobulin  ligands are used. Many, but not all, sera have reactivity to 1~5I- 
J558  (panel B); fewer sera are  reactive with  ~25I-GAC34  (panel  C) or I~I-T15 
(panel D). In most cases, the heterogeneity of the anti-peptide antibodies reacting 
with monoclonal immunoglobulins is much more restricted than those to normal 
IgG.  Further,  antibodies to any one of the monoclonal Iigands seem unrelated SEIDEN ET  AL.  1343 
FIGURE 2.  Western blot analysis of antioJHl sera. Lanes 1 and 2. 500 ng of MOPC 104 and 
mol wt  standards,  respectively, overlaid with  a  1:2,000 dilution  of rabbit  anti-JH~-KLH 
followed by I~sI-SPA. Lanes 3 and 4 same as lanes 1 and 2, except a 1:2,000 dilution of rabbit 
anti-HA-KLH control sera was used as first antibody. Molecular weight markers and location 
of heavy and light chain bands are determined by amido blue-black staining of nitrocellulose 
strips and  are  indicated  on  the  left-hand  border of the  gel. Mol  wt  standards  include 
phosphorylase B, 92.5; BSA, 66.2; ovalbumin, 45; carbonic anhydrase, 31; soybean trypsin 
inhibitor,  21.5; lysozyme, 14.5. HA peptide  sequence is Cys-Lys-Arg-Gly-Pro-Asp-Ser-Gly- 
Tyr. 
to those reactive with the other monoclonal antibodies.  This is best seen in rat 
serum  11, which binds ~25I-J558  very well, yet shows little or no activity for ~5I- 
GAC34. On the other hand, rat serum 4 binds ~25I-GAC34 better than ~5I-J558. 
These results indicate that JH~ induces several separate populations of antibodies 
that  bind  different determinants  in  the JH  segment  and,  secondly,  that  these 
determinants have restricted distribution. 
The second approach to the characterization of anti-peptide antibodies meas- 
ures the fine specificity of binding to various ligands by competition RIA analysis. 
In this procedure, the relative capacities of various unlabeled proteins to inhibit 
the binding of 12~I-labeled monoclonal antibodies to anti-]H1 antibodies measures 
how  closely  the  unlabeled  proteins  resemble  each  other  with  regard  to  the 
antigenic determinant(s) expressed on the labeled proband. Table II summarizes 
the results of these analyses using a  single rabbit anti-JH~  serum  (serum  T) to 
bind  to  three  ligands,  1~5I-M104,  1~5I-T15  and  ~25I-GAC34.  Each  protein  in 1344  SYNTHETIC  IDIOTOPES 
FIGURE 3.  IEF patterns of rat and rabbit anti-peptide antisera.  Rat and rabbit sera were 
focused as described in Materials and Methods. Gels were overlaid with (A) m25I-mouse IgG, 
(B)  levi-Jr58, (C)  125I-GAC34 or (D)  12SI-T15. Lane T contains rabbit anti-JH1-KLH used in 
Fig. 2 and Table II. Lanes 1-11 are sera from individual rats immunized withJH1-KLH. Lanes 
a-d are sera from four rats immunized with bombesin-KLH. Lanes W-Z are sera from four 
rabbits immunized with HA-KLH. All rat sera demonstrate a nonspecific reactivity with 12~l- 
T 15 at tow pH. SEIDEN  ET  AL.  1345 
TABLE  II 
Expression of  JH-Dex, JH-PC, and JH-GAC in Myeloma and Hybridoma Proteins 
Variable region determinants 
Speci-  Protein  Isotype  Jn  D 
ficity  Jn-Dex  JH-PC  J,-GAC 
Dextran  M104  IgM, )`1  Jl 
J558  IgA, )`1  Ji 
Hdexl,2,6,7,9, 13,14  lgM. )`1  J1 
Hdexl0  IgM, ),1  Jl 
Hdex36  IgGs, )`l  Jt 
Hdex4,11,24  IgM, )`1  J~ 
Hdexl2  IgM, )`l  Js 
Hdex31  IgM, )`t  j4 
PC  T15  IgA,K  Jt 
PG-1  IgM,K  Jl 
M511  IgA,K  Jl 
M167  IgA,K  J1 
l-B-10  IgG,K  J1 
6A6  IgG~b,K  Jl 
GAC  GAC34  IgGs,K  ? 
GAC54  IgGs,K  ? 
GAC57  IgGs,K  ? 
GAC35  IgGs,K  ? 
GAC39  IgGs,K  ? 
GAC123  IgM,K  ? 
DNP  M315  IgA,)`2  J~ 
29-13  IgG2bAl  ? 
M460  IgA,K  ? 
Levan  J606  IgGs,K  Js 
M47A  IgA,K  Js 
(relative expression) 
2  100  7  20 
2  75  4  5 
2  100-300  1  ND 
25  9  ND 
60  <1  <1 
100  10  2 
200  1  <1 
200  ND  1 
<1  100  9 
<1  25  5 
4  100  6 
10  140  2 
<1  2  ND 
<1  15  ND 
<1  ND  100 
<1  <1  120 
<1  <1  120 
<1  3  200 
<1  <1  75 
<1  <1  200 
10  5  6 
10  ND  ND 
<1  ND  ND 
10  ND  100 
2  100  2 
Numerous proteins are examined for their expression ofJn-Dex, Jri-PC, and JH-GAC.  Expression of 
JH-Dex, JH-PC,  and Jn-GAC are reported as a  ratio of gg of inhibitor required to generate 50% 
inhibition as compared to standard inhibitors. Values for  50%  inhibition by standards are 40 ng 
GAC34 for JH-GAC, 270 ng T 15 for Jn-PC, and 36 ng M 104 for JH-DEX. D represents the number 
of residues assigned to this segment. 
Table  II  was tested  for the ability to  block the binding of each of the three 
ligands  to  anti-JH~.  The  results  are clear.  All  dextran-specific antibodies are 
capable of blocking 125I-M  104 from binding to anti-JH~; no other protein tested 
had this ability. Similarly, most of the anti-PC antibodies shared a determinant(s) 
with T 15 that was absent from all but one other protein, and all six anti-GAC 
antibodies  expressed  a  determinant(s)  absent  from nearly all  other  proteins. 
Thus, these three distinct determinants, called JH-Dex, Jn-PC, and Jrt-GAC, are 
highly associated with families of proteins sharing antigen specificity. Surpris- 
ingly, at least two of the determinants were not restricted to the JH~-bearing 
antibodies. 
Discussion 
Our goal at the outset of these studies was to produce antibodies specific for 
the individual Ju segments. Instead, we found multiple determinants involving 
JH  segments, each highly restricted in  its distribution  to groups of antibodies 1346  SYNTHETIC  IDIOTOPES 
with similar antigen-binding specificity. Previously, Andrews and Capra (45), as 
well as Schiff and co-workers (46), suggested that idiotopes may be located in 
the J  segment, but could not rule out other portions of the variable domains in 
their assignments. Our surprise comes not from the realization that Jn segments 
can participate in idiotypic determinants, but from the multiplicity of separate 
determinants found within a stretch of 16 amino acids. We believe these results 
require that conformational changes of  Jn residues be induced by other segments 
of the VH domain. To evaluate this hypothesis, it is instructive to consider the 
available structural information pertaining to VH domains. 
Crystallographic studies of the Via domain have demonstrated that this region 
is composed entirely of/3 pleated sheets (43,  47,  48).  In the intact  Fab,  this 
polypeptide chain folds into a  nine-stranded beta barrel  in which each of the 
nine strands is stabilized through hydrogen bonds to neighboring strands. The 
JH segment forms the ninth strand in the beta barrel, is in the immediate vicinity 
of the antigen binding pocket, and interacts through hydrogen bonding with the 
first (residues 1-14) and eighth (residues 91-100) strands of the barrel. Confor- 
mation  of the J  segment  will  be  dependent  on  its  own  primary  sequence, 
influences from neighboring strands, as well as complex interactions with other 
regions of the VH, and the CH~ and VL domains. It is conceivable that changes 
in the length of the D segment, which lies in the hairpin turn of strands eight 
and nine, may play a crucial role in the conformation of theJ segment. This idea 
gains support from the fact that Jia-Dex  is expressed by proteins with short, two- 
residue D segments, while JIa-PC is found on immunoglobulins with 5-7 residue 
D segments. Unfortunately, crystallographic data examining the effect of inser- 
tion or deletion of residues on the secondary and tertiary structure of similar 
proteins is very limited. High resolution crystallographic data of the Via region 
are limited to three proteins: Kol, New, and McPC 603 (43, 47, 48). The New 
Cm  domain has an  additional residue relative to  McPC 603  Cm  (49)  that  is 
accompanied by a  beta bend with minimal distortion of conformation. On the 
other hand, the J  segments of New and Kol demonstrate differences in confor- 
mation; however, interpretation is difficult since only New is sequenced (50). 
Finally, structural data from the Rei and Rhi Bence-Jones dimers have demon- 
strated that  the molecules show different conformations in sequence-identical 
regions because of residue changes in neighboring hypervariable regions (51). 
Therefore, the fragmentary structural data, at the least,  indicate that confor- 
mational changes can be expected in the J  segment that are induced by other 
parts of the variable region. Indeed, these putative conformational determinants 
must accommodate significant changes in primary structure of the J  segment 
itself, because, at least in the case of  JH-Dex, all fourJ segments express the same 
putative conformational determinant. 
Although it is not possible to decide which parts of the variable domains are 
important in imparting the conformational changes to Jn, it is interesting that 
the entire Vn segments of each family of idiotope-bearing molecules are very 
similar. Each family is encoded by one or several very similar Via segment genes. 
This is also true for the anti-levan antibody, J606,  that expresses the JIa-GAC 
determinant. It is conceivable that some "VH" or idiotype markers actually reside 
in the Jia region. The 21A5  idiotype recently described by Morahan and c01- SEIDEN ET AL.  1347 
leagues (52) bears some resemblance to our Jn-PC marker. Since their determi- 
nant is hapten inhibitable and Cn locus-restricted, the idiotype may be located, 
at  least  in  part,  in  the JHI  region.  We  have  found  that  an  anti-JH  peptide 
monoclonal antibody reacts exclusively with t~ chains (unpublished results); this 
suggests that CH regions may influence the conformation of the Jn segments as 
well. 
We believe that anti-peptide antisera will provide an important approach to 
the localization of variable region markers. With this technique, one can confi- 
dently predict in  which section of the variable region an idiotope  is  located. 
Furthermore, by synthesizing several overlapping peptides it may be possible to 
map the location of these idiotopes to a  key residue or residues. Further, this 
technique may also be useful in mapping determinants that have already been 
defined by classical serology. This has recently been demonstrated with antisera 
generated against peptides corresponding to the third hypervariable region of 
M104  and J558  (31).  Conventional  approaches  had  tentatively localized  the 
private idiotypic determinants of these two proteins to the D segment. Antibodies 
directed to peptides corresponding to HV3 were shown to distinguish between 
the proteins in  a  predictable way, confirming the previous conclusions.  More 
interesting,  however, will  be  the surprises  that  emerge from use of this  new 
approach. 
Summary 
In an attempt to better understand the molecular basis of idiotypy, we have 
generated several site-specific antisera  through  immunization of animals  with 
synthetic peptides corresponding to the (JHI) heavy chain joining segment 1 of 
the mouse heavy chain variable  (VH) region.  These anti-peptide sera identify 
several idiotypic determinants present on  intact hybridoma and myeloma im- 
munoglobulins. Expression of at least three of these idiotopes is correlated with 
the antigen specificity of the family of immunoglobulins bearing the determinant. 
Use of synthetic peptides may prove a powerful technique in the generation of 
molecularly defined antiidiotypic reagents. 
We would like to thank Dr. Daniel Cawley for his help in designing  the Western blot 
transfer apparatus and protocol, and Dr. Jerrold Fulton and Dr. Scott Matthews for their 
continuing interest and discussions. 
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